Institutional & Family Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-29
Closed -$3K 934
2020
Q3
$3K Hold
29
﹤0.01% 661
2020
Q2
$3K Sell
29
-9
-24% -$718 ﹤0.01% 659
2020
Q1
$2K Hold
38
﹤0.01% 676
2019
Q4
$2K Hold
38
﹤0.01% 765
2019
Q3
$2K Hold
38
﹤0.01% 733
2019
Q2
$2K Hold
38
﹤0.01% 748
2019
Q1
$2K Hold
38
﹤0.01% 741
2018
Q4
$1K Buy
+38
New +$1.34K ﹤0.01% 791

Other funds holding TNDM

Institutional & Family Asset Management's TNDM Position: Q4 2020 in Review

Institutional & Family Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 29 shares — an estimated $3K sold.

Institutional & Family Asset Management first reported a position in TNDM in Q4 2018 and held it in 8 quarters. The position peaked at $3K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Institutional & Family Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 29 Tandem Diabetes Care shares in Q4 2020, an estimated $3K.
  • Institutional & Family Asset Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 8 quarters.
  • Institutional & Family Asset Management's Tandem Diabetes Care position peaked at $3K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Institutional & Family Asset Management's 13F filing for Q4 2020, filed 3 Feb 2021.